End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
96,300 KRW | +2.77% | +3.44% | -9.32% |
Apr. 25 | OCI Holdings Signs MoU to Accelerate Solar Business | MT |
Apr. 08 | Hanmi Science Co., Ltd. cancelled the transaction announced on January 12, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 3.83 and 3.36 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 665.46 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.32% | 1.37B | B+ | ||
+4.75% | 103B | A- | ||
+2.40% | 68.41B | A- | ||
+42.86% | 39.97B | B | ||
+16.96% | 38.97B | B | ||
+6.96% | 33.12B | A- | ||
+7.89% | 19.41B | B- | ||
+12.12% | 16.73B | C+ | ||
+12.08% | 15.34B | B | ||
+17.69% | 15.07B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- A010060 Stock
- Ratings OCI Holdings Company Ltd.